Ingrezza, a medication used to treat tardive dyskinesia and chorea associated with Huntington's disease, has a significant out-of-pocket cost for patients. On GoodRx, the average retail price for a 30-day supply of Ingrezza (80 mg) can range from $1,500 to over $2,100, depending on the pharmacy and location [1].
How much does Ingrezza cost with insurance?
Insurance coverage for Ingrezza varies by plan. Many commercial insurance plans may offer some level of coverage, but patients often face substantial copayments. The exact cost with insurance depends on the specific benefits of the patient's prescription drug plan, including deductibles, copayments, and coinsurance.
Are there Ingrezza coupons or discount cards available?
Yes, there are discount programs and coupons that can reduce the cost of Ingrezza. The manufacturer, Neurocrine Biosciences, offers a patient assistance program and savings cards that can lower out-of-pocket expenses for eligible commercially insured patients [2]. GoodRx also lists available coupons and discounts that can be applied at the pharmacy to reduce the retail price [1].
What is the list price of Ingrezza?
The list price, or wholesale acquisition cost (WAC), of Ingrezza is considerably higher than what most patients pay after discounts or insurance. While specific list prices can fluctuate, they are generally in the thousands of dollars for a month's supply, contributing to the high out-of-pocket costs when discounts or comprehensive insurance are not utilized.
How does Ingrezza's price compare to other tardive dyskinesia treatments?
When compared to other treatments for tardive dyskinesia, Ingrezza is often among the higher-priced options. Other available medications for tardive dyskinesia may have different pricing structures and market access, influencing the overall cost burden for patients.
When does the patent for Ingrezza expire?
The patent protection for Ingrezza is a critical factor in its pricing and the potential for generic competition. DrugPatentWatch.com tracks patent information for pharmaceuticals. According to available data, Ingrezza's primary patents are expected to expire in the coming years, potentially opening the door for biosimilar or generic versions to enter the market [3].
Can I get Ingrezza without insurance?
Without insurance, patients will be responsible for the full retail price of Ingrezza, which is substantial. Discount programs and savings cards from the manufacturer may offer some relief, but the cost can still be prohibitive. Exploring patient assistance programs is often a necessary step for individuals without adequate insurance coverage.
Sources:
[1] GoodRx. (n.d.). Ingrezza Prices, Coupons, and Patient Assistance Programs. Retrieved from https://www.goodrx.com/ingrezza
[2] Neurocrine Biosciences. (n.d.). Ingrezza Savings Card. Retrieved from https://www.ingrezza.com/savings-and-support
[3] DrugPatentWatch.com. (n.d.). Ingrezza Patent Expiry. Retrieved from https://drugpatentwatch.com/